RYE BROOK, N.Y.--(BUSINESS WIRE)--Jan. 13, 2009--Universal American Corp. (NYSE: UAM) today announced 2009 earnings per
share guidance of between $1.47 and $1.57.
The following table provides additional information relating to our
guidance.
FY 2009
Low High
Diluted EPS
Operating EPS $ 1.47 $ 1.57
Shares Outstanding (millions) 83.0 85.0
Revenue ($ in millions)
Senior Managed Care - Medicare Advantage $2,705 $2,905
Medicare Part D 1,925 2,000
Traditional Insurance 400 425
Total Revenue $5,030 $5,330
End of Year Membership
Medicare Advantage
Private fee-for-service 190,000 210,000
HMOs/PPOs 60,000 65,000
Subtotal Medicare Advantage 250,000 275,000
Medicare Part D 1,550,000 1,650,000
Total Membership 1,800,000 1,925,000
Medicare Advantage Benefit Ratio 83.0% 85.5%
This guidance will be discussed further at the J.P. Morgan Healthcare
Conference, where Universal American is scheduled to present today at
7:30 a.m. Pacific Time. All interested parties are invited to listen to
the webcast of the presentation by visiting www.universalamerican.com
and selecting the Investor Relations tab, followed by Presentations.
Following the conference, a webcast replay will be archived at www.universalamerican.com.
To listen to the live webcast, please visit Universal American's website
at least 15 minutes early to download and install any necessary audio
software. Individuals who listen to the webcast will be presumed to have
read Universal American's most recent filings with the SEC, including
but not limited to its Annual Report on Form 10-K for the year ended
December 31, 2007, and its Quarterly Reports on Form 10-Q for the
reporting periods of 2008.
About Universal American Corp.
Universal American offers a diverse range of healthcare products -
including health insurance, managed care, and prescription drug benefits
- through its subsidiaries. Its companies are collectively among the
leading providers of Medicare Advantage and Medicare prescription drug
plans in the U.S., as over 2 million seniors rely on Universal
American's products for their health or prescription drug coverage. For
more information on Universal American, please visit our website at www.universalamerican.com.
Matters discussed in this news release and oral statements made from
time to time by representatives of Universal American may constitute
forward-looking statements within the meaning of the Private Securities
Litigation Reform Act of 1995 and the Federal securities laws. Although
Universal American believes that the expectations reflected in any
forward-looking statements are based upon reasonable assumptions, it can
give no assurance that its expectations will be achieved.
Forward-looking information is subject to risks, trends and
uncertainties that could cause actual results to differ materially from
those projected. Many of these factors are beyond Universal American's
ability to control or predict. Important factors that may cause actual
results to differ materially and could impact Universal American and the
statements contained in this news release can be found in Universal
American's filings with the Securities and Exchange Commission,
including quarterly reports on Form 10-Q, current reports on Form 8-K
and annual reports on Form 10-K. For forward-looking statements in this
news release, Universal American claims the protection of the safe
harbor for forward-looking statements contained in the Private
Securities Litigation Reform Act of 1995. Universal American assumes no
obligation to update or supplement any forward-looking statements,
whether as a result of new information, future events or otherwise.
CONTACT: Universal American Corp.
Robert A. Waegelein, 914-934-8820
Executive Vice President &
Chief Financial Officer
or
Investor Relations Counsel:
The Equity Group Inc.
Linda Latman, 212-836-9609
www.theequitygroup.com
Source: Universal American Corp.
